Financials

News Discussions Technicals Forecast Seasonals

SGMT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sagimet Biosciences Inc. - Series A

Total assets of SGMT for Q2 24 is 189.02 M USD, 2.83% less than the previous Q1 24. And total liabilities increased by 27.01% in Q2 24 to 5.73 M USD.

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—